未登录

N

Najmeh Edraki

Shiraz University of Medical Sciences

H指数:37

被引数:3,795

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Novel heteroaryl carboxamide derivatives of 5-oxohexahydroquinoline scaffold: Design, synthesis and evaluation of inhibitory profile against MDR1 and BCRP transporters in vitro and in silico

5-氧代六氢喹啉骨架的新型杂芳基羧酰胺衍生物：设计、合成及其对MDR1和BCRP转运蛋白的体外和计算机模拟抑制活性评价

Journal of Molecular Structure

IF4.7

2025-07-300

PRE

Spiroisatin pyranopyrimide derivatives as receptor tyrosine kinase inhibitors and targeted anticancer agents

螺靛红吡喃嘧啶衍生物作为受体酪氨酸激酶抑制剂和靶向抗癌药物

JOURNAL OF MOLECULAR STRUCTURE

IF4.7

2025-06-010

PRE

Novel spiroisatin-pyranopyrazole hybrids as anticancer agents with TrkC inhibitory potential

新型螺异嗪啉-吡喃吡唑杂化物作为具有TrkC抑制潜力的抗癌剂

JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS

IF2.4

2025-03-020

PRE

N-ethyl morpholine-deca hydroacridine 1, 8-diones as novel P-gp inhibitors and multidrug resistance reversal agents in cancer cells

JOURNAL OF MOLECULAR STRUCTURE

IF4.7

2025-03-011

PRE

Synthesis, biological evaluation and molecular modeling studies of methyl indole-isoxazole carbohydrazide derivatives as multi-target anti-Alzheimer's agents

SCIENTIFIC REPORTS

IF3.9

2024-09-104

OAAI

Synthesis and cytotoxic activity evaluation of novel imidazopyridine carbohydrazide derivatives

IF4.6

2024-01-065

OAAI

Novel quinazoline-1,2,3-triazole hybrids with anticancer and MET kinase targeting properties

SCIENTIFIC REPORTS

IF3.9

2023-09-0619

OAAI

5-Oxohexahydroquinolines bearing 4-pyridyl methyl carboxylate as P-glycoprotein inhibitors and multidrug resistance reversal agents in cancer cells

JOURNAL OF MOLECULAR STRUCTURE

IF4.7

2023-08-015

PRE

Novel spiroindoline quinazolinedione derivatives as anticancer agents and potential FLT3 kinase inhibitors

新型螺吲哚啉喹唑啉二酮衍生物作为抗癌剂和潜在的FLT3激酶抑制剂

BIOORGANIC & MEDICINAL CHEMISTRY

IF3

2023-07-0111

PRE

Discovery of anticancer agents with c-Met inhibitory potential by virtual and experimental screening of a chemical library

EUROPEAN JOURNAL OF PHARMACOLOGY

IF4.7

2023-01-014

PRE

Cinnamomum verum J. Presl. Bark essential oil: in vitro investigation of anti-cholinesterase, anti-BACE1, and neuroprotective activity (vol 22, 303, 2022)

BMC COMPLEMENTARY MEDICINE AND THERAPIES

IF3.4

2022-11-290

OAAI

Cinnamomum verum J. Presl. Bark essential oil: in vitro investigation of anti-cholinesterase, anti-BACE1, and neuroprotective activity

BMC COMPLEMENTARY MEDICINE AND THERAPIES

IF3.4

2022-11-188

OAAI

Study of the anticancer effect of new quinazolinone hydrazine derivatives as receptor tyrosine kinase inhibitors

FRONTIERS IN CHEMISTRY

IF4.2

2022-11-1716

OAAI

5-Oxo-hexahydroquinoline and 5-oxo-tetrahydrocyclopentapyridine derivatives as promising antiproliferative agents with potential apoptosis-inducing capacity

MOLECULAR DIVERSITY

IF3.8

2021-10-206

PREAI

Synthesis and evaluation of novel arylisoxazoles linked to tacrine moiety: in vitro in vivo biological activities against Alzheimer's disease

MOLECULAR DIVERSITY

IF3.8

2021-07-1720

PRE

Synthesis and bio-evaluation of new multifunctional methylindolinone-1,2,3-triazole hybrids as anti-Alzheimer's agents

JOURNAL OF MOLECULAR STRUCTURE

IF4.7

2021-04-0133

PREAI

Imidazopyridine hydrazone derivatives exert antiproliferative effect on lung and pancreatic cancer cells and potentially inhibit receptor tyrosine kinases including c-Met

SCIENTIFIC REPORTS

IF3.9

2021-02-1134

OAAI

Design, synthesis, in vitro and in silico studies of novel Schiff base derivatives of 2-hydroxy-4-methoxybenzamide as tyrosinase inhibitors

DRUG DEVELOPMENT RESEARCH

IF4.2

2020-12-1924

PREAI

Design, synthesis and biological activity evaluation of novel carbazole-benzylpiperidine hybrids as potential anti Alzheimer agents

JOURNAL OF MOLECULAR STRUCTURE

IF4.7

2020-12-0131

PREAI

5-Oxo-hexahydroquinoline Derivatives and Their Tetrahydroquinoline Counterparts as Multidrug Resistance Reversal Agents

IF4.6

2020-04-168

OAAI